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Frequent Chromosome Aberrations Revealed by Molecular Cytogenetic
Studies in Patients with Aniridia
John A. Crolla1 and Veronica van Heyningen2
1Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury, United Kingdom; and 2Medical Research Council Human
Genetics Unit, Western General Hospital, Edinburgh
Seventy-seven patients with aniridia, referred for cytogenetic analysis predominantly to assess Wilms tumor risk,
were studied by fluorescence in situ hybridization (FISH), through use of a panel of cosmids encompassing the
aniridia-associated PAX6 gene, the Wilms tumor predisposition gene WT1, and flanking markers, in distal chro-
mosome 11p13. Thirty patients were found to be chromosomally abnormal. Cytogenetically visible interstitial
deletions involving 11p13 were found in 13 patients, 11 of which included WT1. A further 13 patients had cryptic
deletions detectable only by FISH, 3 of which included WT1. Six of these, with deletions !500 kb, share a similar
proximal breakpoint within a cosmid containing the last 10 exons of PAX6 and part of the neighboring gene,
ELP4. Two of these six patients were mosaic for the deletion. The remaining four had chromosomal rearrangements:
an unbalanced translocation, t(11;13), with a deletion including the WAGR (Wilms’ tumor, aniridia, genitourinary
abnormalities, and mental retardation) region, and three balanced rearrangements with what appear to be position
effect breakpoints 3′ of PAX6: (a) a t(7;11) with the 11p13 breakpoint ∼30 kb downstream of PAX6, (b) a dir
ins(12;11) with a breakpoint 150 kb from PAX6, and (c) an inv(11)(p13q13) with a breakpoint 175 kb downstream
of PAX6. The proportion and spectrum of chromosome anomalies in familial (4/14, or 28.5%) and sporadic (26/
63, or 41%) cases are not significantly different. An unexpectedly high frequency of chromosomal rearrangements
is associated with both sporadic and familial aniridia in this cohort.
Introduction
Aniridia (MIM 106200) is a rare developmental defect
affecting the anterior segment of the eye, observed in ∼1
of 50,000–100,000 newborns (Nelson et al. 1984). Spo-
radic cases arise de novo but are subsequently inherited
as an autosomal dominant phenotype, with virtually com-
plete penetrance but variable expressivity. Aniridia gen-
erally occurs in isolation, but it also occurs, more rarely,
as part of the WAGR (Wilms’ tumor, aniridia, genito-
urinary abnormalities, and mental retardation [MIM
194072]) deletion syndrome. WAGR deletions are of var-
iable size but always include part or all of chromosome
band 11p13. WAGR-associated phenotypes were also
found to be variable, even in patients with deletions that
are apparently identical cytogenetically (Franke et al.
1979; Turleau et al. 1984). Subsequently, molecular stud-
ies were used to define the proximal and distal breakpoints
of both visible and submicroscopic deletions in patients
with isolated aniridia and WAGR syndrome–associated
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aniridia (van Heyningen et al. 1985; Davis et al. 1988;
Mannens et al. 1991; Fantes et al. 1992, 1995b;Dreschler
et al. 1994; Crolla et al. 1997; Kent et al. 1997).
Early analysis of such deletions led to the positional
identification of PAX6 and WT1 as candidate genes for
aniridia and Wilms tumor predisposition, respectively
(Call et al. 1990; Gessler et al. 1990; Ton et al. 1991).
WT1 andPAX6map to a 700-kb interval in distal 11p13,
which is within a fully sequenced region (GenBank ac-
cession number NT_009237). Mutations in PAX6, in-
cluding deletions, have been identified in a high propor-
tion of tested patients with either sporadic or familial
aniridia (Fantes et al. 1992, 1995b; Glaser et al. 1992;
Jordan et al. 1992; Hanson et al. 1993; Dreschler et al.
1994; Axton et al. 1997; Grønskov et al. 2001). Early
studies showed that deletions that include the WT1 gene
are correlated with a significant risk of Wilms tumor,
perhaps as high as 60%. More-recent studies have at-
tempted to quantify this empirical risk more accurately,
on the basis of larger samples (Grønskov et al. 2001;
Muto et al. 2002; authors’ unpublished data).
A number of studies have confirmed that human an-
iridia is a haploinsufficiency disorder resulting from in-
activation of one copy of the PAX6 gene, predominantly
through intragenic mutations leading to premature ter-
mination of the protein (reviewed by Prosser and van
Heyningen 1998). However, chromosomal abnormalities
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Figure 1 A, Map showing the position of the four cosmids used in the original FISH deletion analysis. D11Z1 is the centromeric alphoid
repeat probe used to identify the 11 homologues, and D11S317 is a cosmid A4160, which lies ∼400 kb telomeric of FO2121 (see fig. 2). B,
Higher-resolution map showing the relative positions of the cosmid contig covering PAX6 and the ∼180-kb region telomeric of the gene.
including deletions, both visible and cryptic (Mannens et
al. 1991; Fantes et al. 1992, 1995a;Dreschler et al. 1994;
Kent et al. 1997; Crolla et al. 1997; Grønskov et al. 2001;
Muto et al. 2002), and inversions, translocations, and
insertions (Simola et al. 1982; Moore et al. 1986; Man-
nens et al. 1991; Fantes et al. 1995b; Crolla et al. 1996,
1997; Llerena et al. 2000), have also been reported in
association with both isolated sporadic and familial an-
iridia, as well as in patients with WAGR syndrome. More
recently, cell hybrid studies demonstrated inactivation of
two independent, aniridia-associated PAX6 alleles, each
carrying an ∼1,000-kb submicroscopic deletion distal to
PAX6,with the proximal breakpoints at ∼11 kb and ∼22
kb 3′ of the PAX6 polyA addition site (Lauderdale et al.
2000). Analysis of a region ∼150 kb downstream of the
PAX6 transcriptional termination site revealed PAX6-
specific DNAse hypersensitive sites and demonstrated a
number of tissue-specific regulatory elements for PAX6
(Kleinjan et al. 2001; Griffin et al. 2002).
Following the early reports of cryptic 11p13 dele-
tions, a diagnostic FISH service was set up in Salisbury
in 1993, to screen patients presenting with aniridia (par-
ticularly sporadic cases) and identify those with inter-
stitial deletions, so that the extent of the deletion and
the associated empirical Wilms tumor risk could be as-
sessed and reported clinically. Initially, the FISH analysis
used only four cosmids (B2.1, P60, FAT5, and FO2121)
(fig. 1A) (Crolla et al. 1997); however, after the iden-
tification of a patient with a deletion of FO2121 but
not FAT5, an additional six cosmid probes contiguous
with FAT5 were added to the panel (fig. 1B). A further
seven flanking cosmids were used to give estimates of
the overall sizes of the deletions (Fantes et al. 1995a).
Patients 1–19 were initially reported by Crolla et al.
(1997), and, for these patients, only the additional FISH
investigations are presented here.
Subjects and Methods
The Study Population
Seventy-seven patients, falling into four principal cat-
egories, were referred for aniridia/WAGR FISH testing
(table 1):
1. Sporadic isolated aniridia: 43 patients, of whom 38
(88%) were 5 years old at referral (mean  SD
mo). The mean age at referral for all 4313.2 13.4
cases was mo. Patient 94 is an MZ twin43.0 117
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Table 1
Patients by Referral Category and Rates of Abnormality
Referral Category Total No. (%) No. (%) Abnormal
Isolated sporadic aniridia 43 (56) 16 (37)
WAGR 12 (15) 8 (66.6)
Aniridia plus other abnormalities (not WAGR) 8 (10.5) 2 (25)
Familial aniridia 14 (18.5) 4 (28.6)
Total 77 30 (39)
referred with bilateral isolated aniridia and optic at-
rophy. His twin brother is phenotypically normal.
2. WAGR syndrome: 12 patients had aniridia and one
or more of the other features associated with WAGR
syndrome (table 2). Eight were 5 years old at re-
ferral (mean mo). The mean age at re-29.9 26.7
ferral for all 12 patients was mo.96 151
3. Aniridia and additional anomalies (not WAGR): Six
of these eight patients had eye and/or other abnor-
malities in addition to aniridia (table 2). All patients
were 2 years old at referral (mean mo).10.4 9.1
4. Familial aniridia, all independent pedigrees: the age
at referral for the probands in the 14 patients with
familial aniridia ranged from a 38-wk-gestation still-
born infant, who had inherited aniridia from the
mother, to a 57-year-old man. All patients with fa-
milial aniridia were from pedigrees showing aniridia
in two or more generations.
Clinical outcomes have been collated to determine the
empirical risk of developing Wilms tumor in patients
with isolated aniridia who are shown by FISH to have
cryptic or visible constitutional deletions that include
PAX6 and WT1. The results of these studies will be
presented as part of a larger study (authors’ unpublished
data).
Chromosome Preparation, Analysis, and Probe
Labeling
Chromosome preparations were made using conven-
tional techniques. All cases referred for FISH were ex-
amined by the referring laboratories with G banding at
a minimum of 550-band resolution and were reported
using the system recommended by the International Sys-
tem for Human Cytogenetic Nomenclature (table 3). Cy-
togenetic breakpoints for visible deletions and rearrange-
ments are as reported by the referring laboratories.
Whenever possible, spare material from the cytoge-
netic and/or FISH analyses was stored either at 20C
(cell suspensions in 3:1 methanol:acetic acid fixative)
or as lymphoblastoid cell lines. The FISH technique and
analyses were performed as described elsewhere (Crolla
et al. 1997). In brief, cosmids were labeled by nick trans-
lation with digoxigenin and the chromosome 11 centro-
mere probe with biotin. The probe and chromosomal
target DNAs were codenatured at 75C for 5 min and
were incubated overnight at 37C, and, after two 5-min
stringent washes at 42C in 1#SSC/50% formamide,
the sites of hybridization were visualized using antibod-
ies: one layer each of anti-digoxigenin-TRITC (red fluo-
rescence) and avidin-FITC (green fluorescence). Images
were captured using a cooled CCD camera and were
digitized for analysis through use of PSI Powergene soft-
ware. A minimum of 10 metaphases were examined after
hybridization with each probe; for patients 2 and 94,
30 metaphases were scored.
All cases were initially studied using four cosmids
(from centromere to telomere: B2.1, P60, FAT5, and
FO2121; see fig 1A) (Fantes et al. 1995a). Additional
studies were prompted by the results obtained for patient
64, who was not deleted for FAT5 but was hemizygous
for the more telomeric probe, FO2121 (∼100 kb 3′ of
PAX6). All cases previously reported as normal were
subsequently reexamined using the contig of fully se-
quenced cosmids covering the ∼180-kb region 3′ of
PAX6 (fig. 1B). The FISH reexamination with this cos-
mid contig was performed mostly with stored fixed cells.
Three cases were examined using fresh chromosome
preparations derived from stored lymphoblastoid cell
lines. For patient 2, the result was confirmed using chro-
mosome preparations derived from a fresh peripheral
blood sample. In four cases, FISH reexamination was
not possible because no stored material was available,
and these have been excluded from the results.
Anchoring of Cosmids onto the Chromosome 11 Map
Public STSs, gene segments, or sequence data asso-
ciated with each cosmid used (fig. 2) are as follows:
DO8153 (rapsyn, RAPSN), c1-11-474 (D11S1103), c1-
11-458 (D11S1776), B2.1 (WT1), P60 (D11S324),
FAT5 (PAX6, European Molecular Biology Laboratory
[EMBL] accession number Z95332), A1280 (EMBL ac-
cession number Z83307), G0453 (EMBL accession
number Z83301), C1170 (EMBL accession number
Z83306), H1281 (EMBL accession number Z83309),
FO2121 (overlaps H1281 and SRL11M20), SRL11M20
(EMBL accession number Z83308), SRL9A13 (EMBL
accession number Z86001), AO4160 (D11S317),
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Table 2
Clinical Features of Patients with Aniridia and Associated Anomalies
DISORDER AND
PATIENT NUMBER
AGE AT
REFERRAL
(XX/XY
STATUS)
CLINICAL FEATURES
DELETION
(V/C)aW A G R Other Abnormalities
WAGR syndrome:
11b 4 years (XY)     Nystagmus, glaucoma 
12b 1 mo (XY)     Fallot’s tetralogy, 1st and 2nd ribs absent 
14b 2 mo (XY)     Single kidney V
16b 5 years (XY)     C
32 2 mo (XY)     
33 10 mo (XY)     V
34 7 years (XY)     Bilateral cataracts V
36 32 years (XY)     Nystagmus V
41 4 years (XX)     Immunodeficiency V
44 5 years (XY)     Bilateral colobomata 
47 37 years (XY)     V
96 18 mo (XX)     C
Aniridia and other
anomalies:
13b 4 mo (XY)     Optic atrophy V
15b 4 mo (XX)     Facial dysmorphism, glaucoma V
29 2 years (XX)     Left microphthalmia, anterior segment dysgenesis 
45 2 years (XY)     Glaucoma, bicuspid valve, mild stenosis 
50 1 year (XX)     Facial dysmorphism 
68 10 mo (XY)     Glaucoma 
69 4 mo (XY)     Coloboma 
77 1 mo (XY)     Exomphalos, glaucoma 
a V p visible deletion; C p cryptic deletion;  p no deletion.
b Previously reported by Crolla et al. (1997).
CO8160 (D11S151, KCNA4), F1238 (D11S1446), and
EO6182 (D11S1062).
The cosmids B2.1 and P60 and the PAX6 contig cov-
ering the ∼180-kb downstream region (fig. 1B) are avail-
able on request from J.A.C.
Results
The overall frequency of chromosomal abnormalities
found in this cohort of patients with aniridia is sum-
marized in tables 1 and 3 and in figure 2.
Abnormalities by Referral Category
Sporadic isolated aniridia.—Of the 43 patients in this
group, 16 (37%) had chromosome abnormalities that
accounted for their aniridia. Thirteen of the abnormal-
ities were interstitial deletions—eight cryptic and five
cytogenetically visible. Two of the three remaining pa-
tients (patients 1 and 85) had apparently balanced chro-
mosome rearrangements; the third was patient 21, the
child with a t(11;13) with a deletion at the 11p break-
point. All five visible deletions involved WT1, compared
with only one (patient 81) of the eight cryptic deletions.
Five of the six cryptic deletions involving a proximal
breakpoint in cosmid A1280 were ascertained in patients
with sporadic isolated aniridia.
WAGR.—Eight (66.6%) of the 12 patients with WAGR
(tables 2 and 3) had deletions—six visible and two cryptic.
Both cryptic deletions included WT1 (in patients 16 and
96), as did five of the six visible deletions. The one visible
deletion not involvingWT1 (in patient 47) had a proximal
breakpoint between WT1 and P60 (D11S324).
Aniridia and other abnormalities.—Two (25%) of the
eight patients (tables 2 and 3) were chromosomally ab-
normal, both with visible deletions; the deletion in one
patient included WT1 (patient 15), whereas the deletion
in the other patient did not include WT1, with a prox-
imal breakpoint between P60 (D11S324) and PAX6.
Familial aniridia.—Four (28.6%) of the 14 patients
with familial aniridia were chromosomally abnormal;
three cryptic deletions were observed (patients 19, 70,
and 75), the last being one of the patients with a prox-
imal breakpoint in cosmid A1280, and a fourth patient
had a pericentric inversion of chromosome 11.
Visible Deletions
Thirteen (17%) of the patients, all with sporadic an-
iridia, had visible deletions, only two of which (in pa-
tients 13 and 47) did not include WT1. The size of the
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Table 3
Conventional Karyotypes of Patients
Patient
Number Age at Referral Cytogenetic Result (ISCN)
1 2 years 46,XX,t(7;11)(q31.2;p13)
2 1 year 46,XY
6 6 mo 46,XX
13 4 mo 46,XY,del(11)(p13;p15.1)
14 2 mo 46,XY,del(11)(p13;p14.2)
15 4 mo 46,XX,del(11)(p11.2;p14.1)
16 5 years 46,XY
19a 29 years 46,XX
21 2 years 46,XX,t(11;13)(p?13;q?) de novo
25 4 mo 46,XY
26 3 years 46,XY
33 10 mo 46,XY,del(11)(p13p14.2)
34 7 years 46,XY,del(11)(p13p14.3)
36 32 years 46,XY,del(11)(p11.2p14)
41 4 years 46,XX,del(11)(p12p15.1)
42 1 years 46,XX,del(11)(p11.2p13)
47 37 years 46,XY,del(11)(p13p14.3)
51 2 years 46,XX,del(11)(p12p14)
61a 2 years 46,XX,inv(11)(p13q13)mat
64 6 mo 46,XY
70a 38 wk gestation 46,XX
73 4 mo 46,XX,del(11)(p11.2p13)
74 8 mo 46,XX,del(11)(p13p15.1)
75a 1 years 46,XX
81 23 years 46,XX
83 5 mo 46,XY
85 1 mo 46,XY,dir ins(12;11)(q24.11;p13p15.1) de novo
94 2 mo 46,XY
95 3 mo 46,XX,t(2;11)(q33;q25)del(11)(p?12p?13) de novo
96 18 mo 46,XX
a Patient with familial aniridia.
deletions varied (fig. 2), but the two patients with WT1
not deleted had proximal breakpoints between P60 and
FAT5 (patient 13), and WT1 and P60 (patient 47). Seven
of the nine deletions tested with the centromeric FISH
markers had a breakpoint between c1-11-474 and c1-
11-458. Four of these seven shared a similar distal break-
point between F1238 and EO6182 (patients 15, 34, 51,
and 73); two had breakpoints between CO8160 and
F1238 (patients 33 and 95), and patient 74 had a more
distal breakpoint beyond EO6182.
Cryptic Deletions
Thirteen (17%) of the 70 patients had cryptic 11p de-
letions that were visible only when FISH was used (fig.
2). Five of these were not detected in the original analysis,
because the deletion did not include cosmid FAT5 (PAX6
exons 1–4). These deletions were subsequently identified
using the ∼180-kb cosmid contig starting with A1280.
Three of the 13 cryptic deletions included WT1 (patients
16, 81, and 96). Patient 16 presented with Wilms tumor
at age 17 mo, and patient 96 received a diagnosis of Wilms
tumor at age 18 mo. Patient 81 was referred at age 23
years and, apart from visual problems associated with her
aniridia, she was reported to be well and intellectually
normal.
The extent of cryptic deletions was estimated using in-
formation from chromosome 11 mapping (Fantes et al.
1995a) and sequencing around thePAX6 region (Ensembl
Genome Browser). Eleven of the 13 cryptic deletions
ranged in size from ∼75 to !1,500 kb (fig. 2). In patients
16 and 96, the deletion is deduced to cover 900–2,500
kb and 2,500–7,000 kb, respectively. Subsequent con-
ventional reanalysis of these two cases showed that the
deletions were not visible through use of light microscopy.
The cryptic deletions can be further subdivided into
two groups:
1. Six patients had an apparently recurrent common
proximal breakpoint in cosmid A1280, resulting in
a diminished signal on one chromosome 11 homo-
logue (fig. 3A). These deletions ranged in size from
∼80 kb (patient 25) to ∼450 kb (patients 6 and 64).
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Figure 2 Details of the FISH results in the chromosomally abnormal patients. Patient numbers in boldface italic type are those with a
proximal breakpoint in A1280. Shaded areas define the approximate size of the deletion. Size (kb) is the deletion size estimated using known
mapping and sequence data. m p mosaic for deletion; F p familial; / p signal on both homologues; / p one homologue deleted; /
dim p one homologue with diminished signal; mv p cosmid signal moved; st p cosmid signal stays on der(11); split p cosmid signal split;
NT p not tested for this probe; § p cytogenetic breakpoint 11p15 (FISH on distal breakpoint not performed); * p no stored material for
additional FISH; ** p also had t(2;11)(q33;q25) de novo.
In addition, two unrelated patients, 2 and 94, were
mosaics for the deletion, both of which were ∼200
kb in size and present in ∼50% (patient 2) and 60%
(patient 94) of peripheral blood metaphases (fig. 3B).
The diminished A1280 signal suggested that the
proximal breakpoint had occurred either within ex-
ons 5–13 of PAX6, including the ∼1 kb 3′ UTR
(PAX6 3′ UTR), or immediately distal to this region.
In an attempt to resolve this, FISH with three plasmid
probes from the 3′ end of the gene and the 3′ UTR
(fig. 4), was performed on five of the six patients.
Use of the plasmids individually did not yield FISH
signals, but use of all three as pooled FISH probes
gave signal on both 11p13 regions in approximately
half of the metaphases examined (fig. 3C and 3D).
Binding of the plasmid pool suggests that the telo-
meric region of PAX6 is still present, but higher-res-
olution techniques are required to define these break-
points with more precision.
Cosmid A1280 is 34,614 bp long, with its cen-
tromeric end at nucleotide 1 in the sequence given
for EMBL Z83307 and the telomeric end 112 kb into
the sequence for G0453 (EMBL Z83001). Exons
5–13 of PAX6 cover a little more than 15 kb at the
centromeric end of A1280. The final exon (exon 10)
of the ELP4 neighboring gene, transcribed on the
opposite strand to PAX6, stretches over ∼400 bp at
20 kb from the centromeric end of A1280.
2. Seven patients had a proximal breakpoint centromeric
of PAX6. Three of these shared a proximal breakpoint
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Figure 4 Map showing the position of the plasmid and cosmid probes used for FISH
between c1-11-458 and B2.1 (patients 16, 81, and
96). The proximal and distal breakpoints of the re-
maining four were heterogeneous (fig. 2).
Chromosomal Rearrangements
Four patients were identified with chromosomal re-
arrangements involving one breakpoint in distal 11p13
(fig. 2). Patient 1 has an apparently balanced t(7;11)
(Crolla et al. 1996), where the 11p breakpoint appar-
ently lies between adjacent cosmids, with the G0453
signal present on the der(11) and C1170 on the der(7),
placing the breakpoint ∼30 kb 3′ of PAX6. Patient 61,
with familial aniridia, has a pericentric inversion of chro-
mosome 11 (p13q13) with the 11p breakpoint identified
by a split in cosmid H1281, placing the breakpoint 175
kb downstream of PAX6. Patient 85 has an apparent-
ly balanced rearrangement defined as a dir ins(12;11)
where the 11p breakpoint splits cosmid C1170 ∼50 kb
3′ of PAX6. These three chromosomal rearrangements
almost certainly represent position effects leading to het-
erozygous loss of PAX6 function. The overall frequency
of position effects in this series of patients with aniridia
is 3/77 (3.8%).
The fourth chromosomal rearrangement, an appar-
ently balanced t(11;13), was found by FISH to have an
∼7.5-Mb deletion at the breakpoint on the der(11) (Ller-
ena et al. 2000).
Discussion
The Need for Deletion Analysis and Choice of Probes
Since the original identification of PAX6 as the an-
iridia candidate gene, intragenic mutations and chro-
mosomal deletions, translocations, and inversions have
been associated with a high proportion (∼80%) of an-
iridia cases studied in detail (Axton et al. 1997; Crolla
et al. 1997; Grønskov et al. 2001). Most of the intragenic
mutations lead to premature protein truncation (Hanson
et al. 1993; Axton et al. 1997; Prosser and van Hey-
ningen, 1998; Chao et al. 2000) and haploinsufficiency.
FISH analysis is the most efficient way of identifying the
extent of aniridia-associated deletions, both visible and
cryptic. The aim was to ascertain whether patients with
aniridia, particularly children younger than ∼7 years of
age with de novo phenotypes, are deleted for WT1 and
therefore require monitoring for increased risk of Wilms
tumor (Fantes et al. 1992; Crolla 1997; Kent et al. 1997).
FISH analysis, using cosmids B2.1, P60, FAT5, and
FO2121, was also ideal for defining the position of chro-
mosomal breakpoints associated with translocations and
inversions leading to aniridia (Fukushima et al. 1993;
Fantes et al. 1995b; Crolla et al. 1996). Once it became
clear that chromosomal rearrangements with break-
points outside the PAX6 transcription unit could also
lead to classical aniridia phenotypes, the cosmid contig
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used for FISH studies was extended ∼180 kb down-
stream of the PAX6 polyA addition site (fig. 1B).
Cosmid contigs are ideal probes for use in fine deletion
analysis, since the signal is strong enough to be present
reliably, but the genomic insert size (∼30 kb) is small
enough to detect small deletions by loss or diminution
of signal. Some smaller structural changes may be de-
tectable only through pulsed field gel or Southern blot
analysis.
After the setting up of the molecular cytogenetic ser-
vice in Salisbury, through use of the four-cosmid set for
the identification of aniridia-associated deletions, an af-
fected individual was identified who had an intact PAX6
cosmid (FAT5) but was deleted for the more distant
FO2121 (fig. 1A). Subsequently, the extended cosmid
contig (fig. 1B) was used for all new FISH studies and
in a retrospective analysis of earlier samples. Subtle re-
arrangements were defined, with breakpoint positions
identified more accurately.
Unexpectedly High Frequency of Rearrangements
Seen
The spectrum of patients with aniridia sent by clini-
cians for FISH studies was broad: the largest category
comprised patients with isolated sporadic aniridia (43);
patients with syndromic aniridia, including 12 with the
WAGR phenotype, accounted for 20 patients in total,
and analysis was also requested for 14 patients with
familial isolated aniridia (table 1). That 8/12 WAGR
phenotypes were found to be associated with deletions
is not surprising. In contrast, the identification of cryptic
deletions in 8/44 sporadic isolated aniridia cases, (86%
of patients were 5 years old at referral), with no evi-
dence of associated anomalies, was unexpected. A fur-
ther eight of the submitted patients with sporadic iso-
lated aniridia carried previously identified structural
rearrangements or visible deletions. However, one of the
structural rearrangements and all eight cryptic deletions
were only identified in the course of this analysis. Over-
all, 9/44 (20%) of patients with sporadic isolated an-
iridia were found to have unsuspected underlying chro-
mosomal rearrangements.
Perhaps most surprising was the finding of chromo-
somal rearrangements in four independent pedigrees
among the 14 patients with familial aniridia studied,
with three cryptic deletions and a previously identified
cosegregating pericentric inversion. The frequency of un-
suspected aberrations (3/14 [21%]) among patients with
familial aniridia is similar to the frequency in the spo-
radic category. In contrast, Grønskov et al. (2001), using
only FAT5 and B2.1 as FISH probes, found no chro-
mosomal anomalies among 19 patients with familial an-
iridia, but they identified intragenic point mutations in
17 patients. However, some small deletions may not be
identifiable when only these two cosmids are used.
Recurrent Breakpoint Region in Cosmid A1280
Six patients were identified (four retrospectively and
two prospectively) with a diminished A1280 signal (figs.
2 and 3A) and a deletion involving two or more of the
telomeric cosmids in the contig. Cosmid A1280 carries
10 of the 14 PAX6 exons and 115 kb of downstream
region beyond the predicted polyA addition site, which
also contains the final exon of the gene neighboring
PAX6, now known to be the human homologue of tran-
scriptional elongation factor ELP4, first defined in yeast
(Kleinjan et al. 2002). The latest gene prediction pro-
grams also define a predicted additional single-exon
138–amino acid ORF sequence only 2 kb beyond the
PAX6 polyA addition site (like ELP4, transcribed on the
opposite strand). In addition to the six deletion break-
points within A1280 among the current cohort, the cen-
tromeric end of one of the deletions described by Lau-
derdale et al. (2000) is ∼8 kb from the telomeric end of
A1280 (Lauderdale et al. 2000). Sequence comparison
reveals no region-specific low-copy repeats (Stankiewicz
and Lupski 2002) that might be associated with recur-
rent breakpoints, although the last 2 kb at the telomeric
end of A1280 contain two different 50–60-bp segments
that are also found, perfectly repeated, on several other
chromosomes, though not on chromosome 11. The sec-
ond deletion breakpoint described by Lauderdale et al.
(2000) is within cosmid G0453. In view of the high
frequency of breakpoints within this region, the use of
this contig (fig. 1B) may identify aniridia-associated
breakpoints in cases in which conventional sequence-
based mutation analysis fails to find point mutations.
Mosaicism for Cryptic Deletion in Two Patients
with the Aniridia Phenotype
Two of the patients who have a de novo cryptic de-
letion (patients 2 and 94) with a reduced A1280 signal
show the deletion in ∼50% of the peripheral blood meta-
phases (fig. 3B), with the remaining metaphases showing
normal signals on both chromosome 11 homologues. In
both patients, the telomeric breakpoint of the mosaic
deletion is between cosmids SRL9A13 and AO4160 (fig.
2). The results from the use of the pool of the three
plasmid markers over PAX6 exons 10–13 (fig. 4) suggest
reduced FISH signals in these patients, implying trun-
cation of the PAX6 transcription unit by the mosaic
deletion. In both patients, chromosomes have been an-
alyzed only from peripheral blood lymphocytes, so that
the degree of mosaicism in other tissues is not known.
Both of the babies were referred (at ages 12 mo and 2
mo) with bilateral aniridia and optic atrophy, without
any other clinical complications. Optic atrophy is a phe-
notype that has not previously been associated with
PAX6 mutations. Interestingly, the second patient (pa-
tient 94) is an MZ twin with an unaffected brother,
which suggests that somatic mutation in the affected
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twin occurred after the two-blastomere stage, which is
the earliest point at which MZ twinning can occur. The
presence of the normal cell lines in both patients would
have made it very unlikely for the deletions to be detected
using conventional DNA mutation-detection techniques,
so that overall mosaicism involving cryptic deletions
may be underrepresented among patients with aniridia.
Furthermore, the fact that we observed mosaicism in 2
of the 26 deletions overall (2/13 of the microdeletions),
suggests that mosaicism may be underrepresented as
a mutational mechanism in microdeletion syndromes
(Pearson 2002).
Somatic mosaicism for structural chromosome ab-
normalities is a well-recognized but rarely reported phe-
nomenon and has been described for a number of syn-
dromes, including 22q13 deletion (Riegel et al. 2000;
Phelan et al. 2001), neurofibromatosis type 1 (Ainsworth
et al. 1997; Tinschert et al. 2000), 22q11.3 deletion
(Kasprzak et al. 1998), dystrophin (Bunyan et al. 1995),
1p36.33 deletion (Eugster et al. 1997), Angelman syn-
drome 15q11-13 deletion (Tekin et al. 2000), and
19q13.33 deletion (Mikelsaar et al. 2001). Molecular
confirmations of germline mosaicisms for deletions of
22q11.2 (Hatchwell et al. 1998) and Williams-Beuren
syndrome (Kara-Mostefa et al. 1999) have also been
reported.
The observation of the aniridia phenotype in two mo-
saic cases is also surprising, in the light of previous find-
ings that cells carrying heterozygous Pax6 mutations
cannot contribute to lens tissue in artificial mouse chi-
meras (Collinson et al. 2001).
Position Effects as a Mutational Mechanism
Position effects, in which loss or alteration of gene func-
tion results from chromosomal rearrangements outside
the transcribed region of a gene, have been described for
a number of human disease loci (Kleinjan and van Hey-
ningen 1998). On the basis of the cases reported here and
those described in previous studies (Lauderdale et al.
2000; Kleinjan et al. 2001, 2002), it is clear that position-
effect disruptions of PAX6 regulatory element(s) affecting
the chromosomal domain as distant as 180 kb telomeric
of the 3′ end of the gene are rare but important causes of
human sporadic and familial aniridia. In addition to po-
sition-effect breakpoints, we have observed a wide variety
of interstitial deletions varying in size from 75 kb to 7
Mb, which suggests that this region, particularly the∼180
kb immediately telomeric to PAX6, may be a region of
genomic instability.
FISH Analysis Is the Ideal First Choice for Assessing
the Molecular Cause of Sporadic Aniridia
The present study illustrates the importance of FISH
for the characterization of mutations associated with
both familial and sporadic aniridia. The high frequency
of submicroscopic deletions detected suggests that FISH
should be used as the primary screening procedure, par-
ticularly in the neonatal period, in patients ascertained
with sporadic isolated aniridia. Our results, in combi-
nation with those of Lauderdale et al. (2000), also show
that, in order to detect all deletions, it is necessary to
use a contig of FISH probes covering the ∼180-kb region
3′ of PAX6. This is particularly important in young pa-
tients with sporadic isolated aniridia who are reported
to have a normal karyotype by conventional analysis.
In these cases, we recommend that cosmids (listed in
order from centromere to telomere) B2.1, P60, FAT5,
A1280, GO453, C1170, H1281, and FO2121 should
be used as the initial FISH screen. Intragenic mutation-
screening protocols can then be used on those patients
reported to be normal when tested by conventional cy-
togenetics and FISH.
Additional Data Reported Since Submission
of the Present Article
FISH analysis of the phenotypically normal MZ
brother of patient 94 has shown that he is also a mosaic
for the same sized (∼200 kb) cryptic deletion but that
in the peripheral blood, the proportion of deleted cells
is ∼30%, compared with ∼60% in the affected twin
brother. This implies that mosaicism arose before the
splitting of the embryo, or that the twins arose from a
chimeric embryo.
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